News

BioPoly® Oversubscribes $2M Private Equity Offering

December 18, 2019
BioPoly, LLC announced today that it has fully subscribed its latest round of private equity financing of $2M. The financing round also includes oversubscription funding of $890k.
Full Story

BioPoly® Granted Another US Patent

December 3, 2019
BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly® material, which is currently being used to replace damaged cartilage in joints.
Full Story

BioPoly® Granted US Patent

October 17, 2019
FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants.
Full Story

BioPoly Signs Exclusive Distribution Agreement with Hospital Innovations in the UK

July 24, 2019
FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with UK-based distributor, Hospital Innovations Ltd, to distribute the BioPoly® partial resurfacing family of products throughout the UK.
Full Story

BioPoly® Granted European Patent for Its Innovative Implant Design

January 9, 2019
FORT WAYNE, IN – BioPoly LLC has announced that another European patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs.
Full Story

BioPoly® Announces FDA Approval to Initiate Pivotal Clinical Study for Treatment of Cartilage Defects of the Knee

November 16, 2018
FORT WAYNE, IN – BioPoly has just announced that the US FDA has approved an IDE clinical study for its BioPoly® RS Partial Resurfacing Knee System. The BioPoly knee is used to treat patients with painful cartilage lesions by filling the defect with its proprietary implant material known as BioPoly. According to the Company, initiation of the clinical study in the US will happen soon.
Full Story